{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:44:17Z","timestamp":1789523057307,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Early risk stratification for developing retinopathy of prematurity (ROP) is essential for tailoring screening strategies and preventing abnormal retinal development. This study aims to examine the ability of physiological data during the first postnatal month to distinguish preterm infants with and without ROP requiring laser treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this cohort study, preterm infants with a gestational age &lt;32 weeks and\/or birth weight &lt;1500\u2009g, who were screened for ROP were included. Differences in the physiological data between the laser and non-laser group were identified, and tree-based classification models were trained and independently tested to predict ROP requiring laser treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 208 preterm infants were included in the analysis of whom 30 infants (14%) required laser treatment. Significant differences were identified in the level of hypoxia and hyperoxia, oxygen requirement, and skewness of heart rate. The best model had a balanced accuracy of 0.81 (0.72\u20130.87), a sensitivity of 0.73 (0.64\u20130.81), and a specificity of 0.88 (0.80\u20130.93) and included the SpO<jats:sub>2<\/jats:sub>\/FiO<jats:sub>2<\/jats:sub> ratio and baseline demographics (including gestational age and birth weight).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Routinely monitored physiological data from preterm infants in the first postnatal month are already predictive of later development of ROP requiring laser treatment, although validation is required in larger cohorts.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Impact<\/jats:title>\n                <jats:p><jats:list list-type=\"bullet\">\n                  <jats:list-item>\n                    <jats:p>Routinely monitored physiological data from the first postnatal month are predictive of later development of ROP requiring laser treatment, although model performance was not significantly better than baseline characteristics (gestational age, birth weight, sex, multiple birth, prenatal glucocorticosteroids, route of delivery, and Apgar scores) alone.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>A balanced accuracy of 0.81 (0.72\u20130.87), a sensitivity of 0.73 (0.64\u20130.81), and a specificity of 0.88 (0.80\u20130.93) was achieved with a model including the SpO<jats:sub>2<\/jats:sub>\/FiO<jats:sub>2<\/jats:sub> ratio and baseline characteristics.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>Physiological data have potential to play a significant role for future ROP prediction and provide opportunities for early interventions to protect infants from abnormal retinal development.<\/jats:p>\n                  <\/jats:list-item>\n                <\/jats:list><\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41390-023-02504-6","type":"journal-article","created":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T12:07:38Z","timestamp":1676376458000},"page":"699-706","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Early prediction of severe retinopathy of prematurity requiring laser treatment using physiological data"],"prefix":"10.1038","volume":"94","author":[{"given":"Jarinda A.","family":"Poppe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean P.","family":"Fitzgibbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Rob","family":"Taal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjoukje E.","family":"Loudon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Tjiam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles C.","family":"Roehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irwin K. M.","family":"Reiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinno H. P.","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Hartley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,14]]},"reference":[{"key":"2504_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.earlhumdev.2007.11.009","volume":"84","author":"C Gilbert","year":"2008","unstructured":"Gilbert, C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum. Dev. 84, 77\u201382 (2008).","journal-title":"Early Hum. Dev."},{"key":"2504_CR2","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1136\/archdischild-2018-316464","volume":"105","author":"MG Gantz","year":"2020","unstructured":"Gantz, M. G. et al. Achieved oxygen saturations and retinopathy of prematurity in extreme preterms. Arch. Dis. Child. Fetal Neonatal Ed. 105, 138\u2013144 (2020).","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"2504_CR3","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/ANC.0b013e318225a332","volume":"11","author":"AJ Mitchell","year":"2011","unstructured":"Mitchell, A. J., Green, A., Jeffs, D. A. & Roberson, P. K. Physiologic effects of retinopathy of prematurity screening examinations. Adv. Neonatal Care 11, 291\u2013297 (2011).","journal-title":"Adv. Neonatal Care"},{"key":"2504_CR4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000079542","volume":"86","author":"S Belda","year":"2004","unstructured":"Belda, S., Pallas, C. R., De la Cruz, J. & Tejada, P. Screening for retinopathy of prematurity: is it painful? Biol. Neonate 86, 195\u2013200 (2004).","journal-title":"Biol. Neonate"},{"key":"2504_CR5","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.ophtha.2015.11.003","volume":"123","author":"AK Hutchinson","year":"2016","unstructured":"Hutchinson, A. K. et al. Clinical models and algorithms for the prediction of retinopathy of prematurity: a Report by the American Academy of Ophthalmology. Ophthalmology 123, 804\u2013816 (2016).","journal-title":"Ophthalmology"},{"key":"2504_CR6","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.survophthal.2018.04.002","volume":"63","author":"SJ Kim","year":"2018","unstructured":"Kim, S. J. et al. Retinopathy of prematurity: a review of risk factors and their clinical significance. Surv. Ophthalmol. 63, 618\u2013637 (2018).","journal-title":"Surv. Ophthalmol."},{"key":"2504_CR7","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/nm1336","volume":"11","author":"E Kermorvant-Duchemin","year":"2005","unstructured":"Kermorvant-Duchemin, E. et al. Trans-arachidonic acids generated during nitrative stress induce a thrombospondin-1-dependent microvascular degeneration. Nat. Med. 11, 1339\u20131345 (2005).","journal-title":"Nat. Med."},{"key":"2504_CR8","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s12291-011-0180-9","volume":"27","author":"U Garg","year":"2012","unstructured":"Garg, U. et al. Free radical status in retinopathy of prematurity. Indian J. Clin. Biochem. 27, 196\u2013199 (2012).","journal-title":"Indian J. Clin. Biochem."},{"key":"2504_CR9","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1056\/NEJMoa0911781","volume":"362","author":"WA Carlo","year":"2010","unstructured":"Carlo, W. A. et al. Target ranges of oxygen saturation in extremely preterm infants. N. Engl. J. Med. 362, 1959\u20131969 (2010).","journal-title":"N. Engl. J. Med."},{"key":"2504_CR10","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1056\/NEJMoa1302298","volume":"368","author":"BJ Stenson","year":"2013","unstructured":"Stenson, B. J. et al. Oxygen saturation and outcomes in preterm infants. N. Engl. J. Med. 368, 2094\u20132104 (2013).","journal-title":"N. Engl. J. Med."},{"key":"2504_CR11","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1001\/jama.2013.5555","volume":"309","author":"B Schmidt","year":"2013","unstructured":"Schmidt, B. et al. Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial. JAMA 309, 2111\u20132120 (2013).","journal-title":"JAMA"},{"key":"2504_CR12","doi-asserted-by":"crossref","unstructured":"Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), a randomized, controlled trial. I: Primary outcomes. Pediatrics 105, 295\u2013310 (2000).","DOI":"10.1542\/peds.105.2.295"},{"key":"2504_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/pne2.12065","volume":"3","author":"C Hartley","year":"2021","unstructured":"Hartley, C. Toward personalized medicine for pharmacological interventions in neonates using vital signs. Paediatr. Neonatal Pain 3, 147\u2013155 (2021).","journal-title":"Paediatr. Neonatal Pain"},{"key":"2504_CR14","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3389\/fphar.2020.00665","volume":"11","author":"JA Poppe","year":"2020","unstructured":"Poppe, J. A. et al. Precision dosing of doxapram in preterm infants using continuous pharmacodynamic data and model-based pharmacokinetics: an illustrative case series. Front. Pharmacol. 11, 665 (2020).","journal-title":"Front. Pharmacol."},{"key":"2504_CR15","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1159\/000509269","volume":"117","author":"JA Poppe","year":"2020","unstructured":"Poppe, J. A. et al. Use of continuous physiological monitor data to evaluate doxapram therapy in preterm infants. Neonatology 117, 438\u2013445 (2020).","journal-title":"Neonatology"},{"key":"2504_CR16","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1055\/s-0038-1654712","volume":"35","author":"BA Sullivan","year":"2018","unstructured":"Sullivan, B. A. et al. Early pulse oximetry data improves prediction of death and adverse outcomes in a two-center cohort of very low birth weight infants. Am. J. Perinatol. 35, 1331\u20131338 (2018).","journal-title":"Am. J. Perinatol."},{"key":"2504_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1001\/jamaophthalmol.2019.4502","volume":"138","author":"A Pivodic","year":"2020","unstructured":"Pivodic, A. et al. Individual risk prediction for sight-threatening retinopathy of prematurity using birth characteristics. JAMA Ophthalmol. 138, 21\u201329 (2020).","journal-title":"JAMA Ophthalmol."},{"key":"2504_CR18","first-page":"248","volume":"102","author":"WV Good","year":"2004","unstructured":"Good, W. V. & Early Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial. Trans. Am. Ophthalmol. Soc. 102, 248\u2013250 (2004); discussion 233\u2013248.","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"2504_CR19","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1016\/S0140-6736(18)31813-0","volume":"392","author":"C Hartley","year":"2018","unstructured":"Hartley, C. et al. Analgesic efficacy and safety of morphine in the Procedural Pain in Premature Infants (Poppi) Study: randomised placebo-controlled trial. Lancet 392, 2595\u20132605 (2018).","journal-title":"Lancet"},{"key":"2504_CR20","unstructured":"Meyer, D. et al. E1071: misc functions of the Department of Statistics, Probability Theory Group (Formerly: E1071), Tu Wien [R Package Version 1.7-9]. https:\/\/CRAN.R-project.org\/package=e1071 (2021)."},{"key":"2504_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jneumeth.2007.03.024","volume":"164","author":"E Maris","year":"2007","unstructured":"Maris, E. & Oostenveld, R. Nonparametric statistical testing of EEG- and MEG-Data. J. Neurosci. Methods 164, 177\u2013190 (2007).","journal-title":"J. Neurosci. Methods"},{"key":"2504_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-13-91","volume":"13","author":"MW Fagerland","year":"2013","unstructured":"Fagerland, M. W., Lydersen, S. & Laake, P. The Mcnemar test for binary matched-pairs data: mid-P and asymptotic are better than exact conditional. BMC Med. Res. Methodol. 13, 91 (2013).","journal-title":"BMC Med. Res. Methodol."},{"key":"2504_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/pne2.12007","volume":"1","author":"M van der Vaart","year":"2019","unstructured":"van der Vaart, M. et al. Multimodal pain assessment improves discrimination between noxious and non-noxious stimuli in infants. Paediatr. Neonatal Pain 1, 21\u201330 (2019).","journal-title":"Paediatr. Neonatal Pain"},{"key":"2504_CR24","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/pr.2012.132","volume":"72","author":"JM Di Fiore","year":"2012","unstructured":"Di Fiore, J. M. et al. The relationship between patterns of intermittent hypoxia and retinopathy of prematurity in preterm infants. Pediatr. Res. 72, 606\u2013612 (2012).","journal-title":"Pediatr. Res."},{"key":"2504_CR25","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/jp.2016.131","volume":"36","author":"ZA Vesoulis","year":"2016","unstructured":"Vesoulis, Z. A., Lust, C. E., Liao, S. M., Trivedi, S. B. & Mathur, A. M. Early hyperoxia burden detected by cerebral near-infrared spectroscopy is superior to pulse oximetry for prediction of severe retinopathy of prematurity. J. Perinatol. 36, 966\u2013971 (2016).","journal-title":"J. Perinatol."},{"key":"2504_CR26","doi-asserted-by":"crossref","unstructured":"Srivatsa, B., Hagan, J. L., Clark, R. H. & Kupke, K. G. Oxygenation factors associated with retinopathy of prematurity in infants of extremely low birth weight. J. Pediatr. 247, 46.e4\u201352.e4 (2022).","DOI":"10.1016\/j.jpeds.2022.03.057"},{"key":"2504_CR27","doi-asserted-by":"publisher","first-page":"e0267576","DOI":"10.1371\/journal.pone.0267576","volume":"17","author":"T Tedeschi","year":"2022","unstructured":"Tedeschi, T., Lee, K., Zhu, W. & Fawzi, A. A. Limited hyperoxia-induced proliferative retinopathy: a model of persistent retinal vascular dysfunction, preretinal fibrosis and hyaloidal vascular reprogramming for retinal rescue. PLoS ONE 17, e0267576 (2022).","journal-title":"PLoS ONE"},{"key":"2504_CR28","doi-asserted-by":"crossref","unstructured":"Pivodic, A. et al. Development and validation of a new clinical decision support tool to optimize screening for retinopathy of prematurity. Br. J. Ophthalmol. 106, 1573\u20131580 (2021).","DOI":"10.1136\/bjophthalmol-2020-318719"},{"key":"2504_CR29","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1001\/jamaophthalmol.2018.2753","volume":"136","author":"G Binenbaum","year":"2018","unstructured":"Binenbaum, G. et al. Development of modified screening criteria for retinopathy of prematurity: primary results from the postnatal growth and retinopathy of prematurity study. JAMA Ophthalmol. 136, 1034\u20131040 (2018).","journal-title":"JAMA Ophthalmol."},{"key":"2504_CR30","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/s41390-018-0128-3","volume":"84","author":"R Gerull","year":"2018","unstructured":"Gerull, R. et al. Prediction of ROP treatment and evaluation of screening criteria in vlbw infants-a population based analysis. Pediatr. Res. 84, 632\u2013638 (2018).","journal-title":"Pediatr. Res."},{"key":"2504_CR31","doi-asserted-by":"publisher","first-page":"e73256","DOI":"10.1371\/journal.pone.0073256","volume":"8","author":"P Lundgren","year":"2013","unstructured":"Lundgren, P. et al. Winrop identifies severe retinopathy of prematurity at an early stage in a nation-based cohort of extremely preterm infants. PLoS ONE 8, e73256 (2013).","journal-title":"PLoS ONE"},{"key":"2504_CR32","first-page":"178","volume":"8","author":"N Valikodath","year":"2019","unstructured":"Valikodath, N., Cole, E., Chiang, M. F., Campbell, J. P. & Chan, R. V. P. Imaging in retinopathy of prematurity. Asia Pac. J. Ophthalmol. 8, 178\u2013186 (2019).","journal-title":"Asia Pac. J. Ophthalmol."},{"key":"2504_CR33","doi-asserted-by":"publisher","first-page":"e2217447","DOI":"10.1001\/jamanetworkopen.2022.17447","volume":"5","author":"Q Wu","year":"2022","unstructured":"Wu, Q. et al. Development and validation of a deep learning model to predict the occurrence and severity of retinopathy of prematurity. JAMA Netw. Open 5, e2217447 (2022).","journal-title":"JAMA Netw. Open"},{"key":"2504_CR34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41390-021-01428-3","volume":"90","author":"AM Zimmet","year":"2021","unstructured":"Zimmet, A. M. et al. Vital sign metrics of VLBW infants in three nicus: implications for predictive algorithms. Pediatr. Res. 90, 125\u2013130 (2021).","journal-title":"Pediatr. Res."},{"key":"2504_CR35","doi-asserted-by":"publisher","unstructured":"Trzcionkowska, K., Termote, J. U., Bohringer, S., van Sorge, A. J. & Schalij-Delfos, N. Nationwide inventory on retinopathy of prematurity screening in the Netherlands. Br. J. Ophthalmol. https:\/\/doi.org\/10.1136\/bjophthalmol-2021-319929 (2021).","DOI":"10.1136\/bjophthalmol-2021-319929"},{"key":"2504_CR36","doi-asserted-by":"publisher","first-page":"F337","DOI":"10.1136\/archdischild-2017-313574","volume":"103","author":"R Gerull","year":"2018","unstructured":"Gerull, R. et al. Incidence of retinopathy of prematurity (ROP) and ROP treatment in Switzerland 2006-2015: a population-based analysis. Arch. Dis. Child. Fetal Neonatal Ed. 103, F337\u2013F342 (2018).","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02504-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02504-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02504-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T13:16:15Z","timestamp":1690550175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02504-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,14]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["2504"],"URL":"https:\/\/doi.org\/10.1038\/s41390-023-02504-6","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,14]]},"assertion":[{"value":"25 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The medical ethics committee of the Erasmus University Medical Center granted a waiver from approval for this study according to the Dutch Medical Research Involving Human Subjects Act (MEC-2018\u20131106).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}